ES2076226T3 - Utilizacion de trifluorometilfeniltetrahidropiridinas para la preparacion de medicamentos destinados para combatir las alteraciones ansio-depresivas. - Google Patents

Utilizacion de trifluorometilfeniltetrahidropiridinas para la preparacion de medicamentos destinados para combatir las alteraciones ansio-depresivas.

Info

Publication number
ES2076226T3
ES2076226T3 ES89403164T ES89403164T ES2076226T3 ES 2076226 T3 ES2076226 T3 ES 2076226T3 ES 89403164 T ES89403164 T ES 89403164T ES 89403164 T ES89403164 T ES 89403164T ES 2076226 T3 ES2076226 T3 ES 2076226T3
Authority
ES
Spain
Prior art keywords
group
depressive
trifluorometilfeniltetrahidropiridinas
ansio
combat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89403164T
Other languages
English (en)
Inventor
Alberto Bianchetti
Fur Gerard Le
Jacques Simiand
Philippe Soubrie
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Application granted granted Critical
Publication of ES2076226T3 publication Critical patent/ES2076226T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A LA UTILIZACION DE TRIFLUOROMETIL-FENILTETRA-HIDROPIRIDINAS DE FORMULA (I), EN LA QUE ALK REPRESENTA UN GRUPO ALQUILENO DE CADENA RECTA O RAMIFICADA QUE TIENE 1-4 ATOMOS DE CARBONO Y R ES UN GRUPO CIANO, ACETILO, CICLOALQUILO QUE TIENE 3-7 ATOMOS DE CARBONO, PIRIDILO, PIRIDILO 1-OXIDO O NAFTILO, Y SUS SALES FARMACEUTICAMENTE ACEPTABLES, COMO PRINCIPIOS ACTIVOS PARA LA PREPARACION DE MEDICAMENTOS DESTINADOS A COMBATIR LA ANXIEDAD Y LOS TRASTORNOS ANXIO-DEPRESIVOS.
ES89403164T 1988-11-18 1989-11-17 Utilizacion de trifluorometilfeniltetrahidropiridinas para la preparacion de medicamentos destinados para combatir las alteraciones ansio-depresivas. Expired - Lifetime ES2076226T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8815036A FR2639226B1 (fr) 1988-11-18 1988-11-18 Utilisation de trifluoromethylphenyltetrahydropyridines pour la preparation de medicaments destines a combattre les troubles anxio-depressifs

Publications (1)

Publication Number Publication Date
ES2076226T3 true ES2076226T3 (es) 1995-11-01

Family

ID=9371983

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89403164T Expired - Lifetime ES2076226T3 (es) 1988-11-18 1989-11-17 Utilizacion de trifluorometilfeniltetrahidropiridinas para la preparacion de medicamentos destinados para combatir las alteraciones ansio-depresivas.

Country Status (9)

Country Link
US (1) US5026716A (es)
EP (1) EP0369887B1 (es)
JP (1) JP2904827B2 (es)
AT (1) ATE123944T1 (es)
CA (1) CA2003289C (es)
DE (1) DE68923151T2 (es)
ES (1) ES2076226T3 (es)
FR (1) FR2639226B1 (es)
GR (1) GR3017242T3 (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2662355B1 (fr) * 1990-05-22 1994-11-10 Sanofi Sa Utilisation de la 1-[2-(2-naphtyl)ethyl]-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine pour la preparation de medicaments destines au traitement de troubles cerebraux et neuronaux.
US5618822A (en) * 1990-05-23 1997-04-08 Sanofi N-substituted trifluoromethylphenyltetrahydropyridines, process for the preparation thereof, intermediates in said process and pharmaceutical compositions containing them
FR2662442A1 (fr) * 1990-05-23 1991-11-29 Midy Spa Trifluoromethylphenyltetrahydropyridines n-substituees procede pour leur preparation, intermediaires du procede et compositions pharmaceutiques les contenant.
FR2672213B1 (fr) * 1991-02-05 1995-03-10 Sanofi Sa Utilisation de derives 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridiniques comme capteurs de radicaux libres.
FR2690158B1 (fr) * 1992-04-17 1994-07-22 Sanofi Elf Nouveau derive arylpiperidinique, procede pour sa preparation et compositions pharmaceutiques le contenant.
FR2702656B1 (fr) * 1993-03-18 1995-06-16 Sanofi Elf Utilisation de derives de la tetrahydropyridine pour la preparation de medicaments cardioprotecteurs.
FR2721513B1 (fr) * 1994-06-23 1996-09-06 Lafon Labor Utilisation de dérivés de 1,2,5,6-tétrahydropyridine pour la fabrication de médicaments à effet sédatif.
FR2757510B1 (fr) * 1996-12-23 2000-01-07 Sanofi Sa Forme microparticulaire d'un derive de tetrahydropyridine
SE9904723D0 (sv) 1999-12-22 1999-12-22 Carlsson A Research Ab New modulators of dopamine neurotransmission II
USRE46117E1 (en) 1999-12-22 2016-08-23 Teva Pharmaceuticals International Gmbh Modulators of dopamine neurotransmission
SE9904724D0 (sv) * 1999-12-22 1999-12-22 Carlsson A Research Ab New modulators of dopamine neurotransmission I
AU2005251906B2 (en) 2004-06-08 2011-03-31 Nsab, Filial Af Neurosearch Sweden Ab, Sverige New disubstituted phenylpiperidines/piperazines as modulators of dopamine neurotransmission
US7851629B2 (en) 2004-06-08 2010-12-14 Nsab, Filial Af Neurosearch Sweden Ab, Sverige Disubstituted phenylpiperidines as modulators of dopamine and serotonin neurotransmission
SE0401465D0 (sv) 2004-06-08 2004-06-08 Carlsson A Research Ab New substituted piperdines as modulators of dopamine neurotransmission
DE602005021641D1 (de) 2004-06-08 2010-07-15 Nsab, Filial Af Neurosearch Sweden Ab Neue disubstituierte phenylpiperidine und piperazine als modulatoren der dopamin-neurotransmission
WO2006040155A1 (en) 2004-10-13 2006-04-20 Neurosearch Sweden Ab Process for the synthesis of 4-(3-methanesulfonylphenyl)-1-n-propyl-piperidine
SE529246C2 (sv) 2005-10-13 2007-06-12 Neurosearch Sweden Ab Nya disubstituerade fenyl-piperidiner som modulatorer för dopaminneurotransmission
MX347209B (es) 2011-12-08 2017-04-19 Teva Pharmaceuticals Int Gmbh La sal de bromhidrato de pridopidina.
MX2014011971A (es) 2012-04-04 2015-01-16 Ivax Int Gmbh Composiciones farmaceuticas para terapia de combinacion.

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2501682A1 (fr) * 1981-03-11 1982-09-17 Sanofi Sa Trifluoromethylphenylpyridines a activite anorexigene, un procede de preparation et compositions pharmaceutiques en contenant
FR2501506A1 (fr) * 1981-03-11 1982-09-17 Sanofi Sa Compositions pharmaceutiques a action anorexigene contenant des derives de la tetrahydropyridine
US4691019A (en) * 1981-03-11 1987-09-01 Sanofi Anorectic agent; 4-(3-trifluoromethylphenyl)-1-(2-cyanoethyl)-1,2,3,6-tetrahydropyridine
US4485109A (en) * 1982-05-07 1984-11-27 E. I. Du Pont De Nemours And Company 4-Aryl-4-piperidinecarbinols
FR2531707A1 (fr) * 1982-08-16 1984-02-17 Midy Spa Trifluoromethylphenyltetrahydropyridines substituees a activite anorexigene, un procede de preparation et compositions pharmaceutiques
DE3421641A1 (de) * 1984-06-09 1985-12-12 Merck Patent Gmbh, 6100 Darmstadt Indolderivate
US4649161A (en) * 1986-06-16 1987-03-10 Massachusetts Institute Of Technology Method for treating depression with d-fenfluramine

Also Published As

Publication number Publication date
CA2003289C (en) 2000-07-18
DE68923151T2 (de) 1996-02-01
ATE123944T1 (de) 1995-07-15
EP0369887A3 (fr) 1991-12-18
FR2639226B1 (fr) 1993-11-05
CA2003289A1 (en) 1990-05-18
US5026716A (en) 1991-06-25
EP0369887B1 (fr) 1995-06-21
DE68923151D1 (de) 1995-07-27
FR2639226A1 (fr) 1990-05-25
EP0369887A2 (fr) 1990-05-23
JPH02256663A (ja) 1990-10-17
GR3017242T3 (en) 1995-11-30
JP2904827B2 (ja) 1999-06-14

Similar Documents

Publication Publication Date Title
ES2076226T3 (es) Utilizacion de trifluorometilfeniltetrahidropiridinas para la preparacion de medicamentos destinados para combatir las alteraciones ansio-depresivas.
DK275488A (da) Indolonderivater
DE3576912D1 (de) Kombinationspraeparat aus xanthinderivaten und o-acetylsalicylsaeure bzw. deren pharmakologisch vertraeglichen salzen und dessen verwendung.
MX173630B (es) Derivados de aminoacido, procedimiento para su preparacion y su preparacion y medicamento que los contiene
DE69604714T2 (de) Stilbenderivate und diese enthaltende pharmazeutische Zusammensetzungen
ES2111352T3 (es) Uso de diester fosfato para el tratamiento de enfermedades retinianas.
DK0476066T3 (da) Antiviralt præparat indeholdende 3-azido-2,3-dideoxy-5-methylcytidin
ES2109752T3 (es) Medicamento para tratamiento terapeutico y profilactico de enfermedades causadas por hiperplasia de las celulas de los musculos lisos.
DE68926972T2 (de) Thienotriazoldiazepinverbindungen und deren pharmazeutische Anwendungen
ATE122562T1 (de) Derivate von penciclovir zur behandlung von hepatitis-b-infektionen.
KR910015300A (ko) 부스피론 : 수면 무호흡증의 치료용도
PT90816A (pt) Processo para a preparacao de composicoes farmaceuticas contendo analogos de 2',5'-oligoadenilato
DK619484A (da) Farmaceutisk praeparat mod rheumatiske lidelser
ES2134284T3 (es) Pirido-pirimidindionas, procedimiento para su preparacion y su empleo como medicamentos.
ES2072332T3 (es) Derivados de la dibenzo(1,5)dioxocin-5-ona, su uso en medicamentos y procedimiento para su fabricacion.
CO4930262A1 (es) Producto farmaceutico cristalino, su preparacion y uso como sustancia terapeutica
DK0855398T3 (da) Sesquiterpenderivater med antiviral aktivitet
ES2065192T3 (es) Nuevos nicotinatos de diacil-glicerol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
PT728002E (pt) Utilizacao de derivados de 2-amino purina para o tratamento e profilaxia da infeccao pelo virus de herpes 7 humano
FI890173A (fi) Isoxazoler med nootropisk verkan.
MX9302929A (es) Derivados de tetrahidro y perhidroisoquinolina y medios terapeuticos que los contienen.
KR910018026A (ko) α-페닐-α피리딜알칸산 유도체를 함유하는 배뇨장애증상 치료제
RU2001115094A (ru) Нуклеозиды, обладающие активностью против вируса гепатита в
PT728001E (pt) Utilizacao de derivados de 2-amino-purina para o tratamento e profilaxia das infeccoes pelo virus de herpes humano.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 369887

Country of ref document: ES